SEC Form D private-offering filing

Climb Bio, Inc.

Name: Climb Bio, Inc. - new SEC Form D private-offering filing, Wellesley Hills, MA
Published: 2026-05-04

A new SEC Form D private-offering notice from Wellesley Hills, MA, a $110,076,289 filer-stated offering target in Biotech. The source filing is one click away.

Climb Bio, Inc. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing monoclonal antibody therapies for immune mediated diseases, including budoprutug for B cell mediated conditions.

Filed 2026-05-04Filed to raise $110,076,289First money in 2026-04-29Raised so far $110,076,289HQ (as filed) Wellesley Hills, MASector Biotech ✓Stage (inferred) LateCall status Call-ready

Source linked the Form D on EDGAR↗Website verified climbbio.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.